(Q47155090)

9 January 2018

title

Nanobodies effectively modulate the enzymatic activity of CD38 and allow specific imaging of CD38+ tumors in mouse models in vivo (English)

1 reference

9 January 2018

Yong Juan Zhao

14

0 references

Fernando A Goldbaum

object named as

Fernando Goldbaum

17

0 references

Friedrich Koch-Nolte

object named as

Friedrich Koch-Nolte

21

0 references

author name string

William Fumey

1

1 reference

9 January 2018

Julia Koenigsdorf

2

1 reference

9 January 2018

Valentin Kunick

3

1 reference

9 January 2018

Stephan Menzel

4

1 reference

9 January 2018

Kerstin Schütze

5

1 reference

9 January 2018

Mandy Unger

6

1 reference

9 January 2018

Levin Schriewer

7

1 reference

9 January 2018

Friedrich Haag

8

1 reference

9 January 2018

Gerhard Adam

9

1 reference

9 January 2018

Anna Oberle

10

1 reference

9 January 2018

Mascha Binder

11

1 reference

9 January 2018

Ralf Fliegert

12

1 reference

9 January 2018

Andreas Guse

13

1 reference

9 January 2018

Hon Cheung Lee

15

1 reference

9 January 2018

Fabio Malavasi

16

1 reference

9 January 2018

Rob van Hegelsom

18

1 reference

9 January 2018

Catelijne Stortelers

19

1 reference

9 January 2018

Peter Bannas

20

1 reference

9 January 2018

language of work or name

English

0 references

publication date

30 October 2017

1 reference

9 January 2018

published in

Scientific Reports

1 reference

9 January 2018

volume

7

1 reference

9 January 2018

issue

1

1 reference

9 January 2018

page(s)

14289

1 reference

9 January 2018

Creative Commons Attribution 4.0 International

copyright license

start time

30 October 2017

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Roles and Modalities of Ectonucleotidases in Remodeling the Multiple Myeloma Niche

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Immuno-targeting the multifunctional CD38 using nanobody

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Nanobodies as therapeutics: big opportunities for small antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Construction and expression of an anti-VEGFR2 Nanobody-Fc fusionbody in NS0 host cell.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Monoclonal antibodies targeting CD38 in hematological malignancies and beyond

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Clinical efficacy and management of monoclonal antibodies targeting CD38 and SLAMF7 in multiple myeloma.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Strategy for the treatment of multiple myeloma utilizing monoclonal antibodies: A new era begins

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Molecular imaging of tumors with nanobodies and antibodies: Timing and dosage are crucial factors for improved in vivo detection

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Selection of nanobodies that block the enzymatic and cytotoxic activities of the binary Clostridium difficile toxin CDT

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Radiolabeled nanobodies as theranostic tools in targeted radionuclide therapy of cancer

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

SAR650984, a novel humanized CD38-targeting antibody, demonstrates potent antitumor activity in models of multiple myeloma and other CD38+ hematologic malignancies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Nanobodies: natural single-domain antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Rapid visualization of human tumor xenografts through optical imaging with a near-infrared fluorescent anti-epidermal growth factor receptor nanobody.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Daratumumab, a novel therapeutic human CD38 monoclonal antibody, induces killing of multiple myeloma and other hematological tumors.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Single-domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP-ribosylating toxin of Salmonella typhimurium

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

CD38/CD31 interactions activate genetic pathways leading to proliferation and migration in chronic lymphocytic leukemia cells

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

The development of nanobodies for therapeutic applications.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Production of chimeric heavy-chain antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

General strategy to humanize a camelid single-domain antibody and identification of a universal humanized nanobody scaffold

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Evolution and function of the ADP ribosyl cyclase/CD38 gene family in physiology and pathology

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

CD38 at the junction between prognostic marker and therapeutic target.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Single domain antibodies from llama effectively and specifically block T cell ecto-ADP-ribosyltransferase ART2.2 in vivo

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Crystal structure of human CD38 extracellular domain

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Llama single domain antibodies as a tool for molecular mimicry

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Application of monoclonal antibodies in functional and comparative investigations of heavy-chain immunoglobulins in new world camelids

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Potent enzyme inhibitors derived from dromedary heavy-chain antibodies

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Formation and hydrolysis of cyclic ADP-ribose catalyzed by lymphocyte antigen CD38.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Adjuvant properties of stable water-in-oil emulsions: evaluation of the experience with Specol

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Nanobodies that block gating of the P2X7 ion channel ameliorate inflammation.

23 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Improved tumor targeting of anti-epidermal growth factor receptor Nanobodies through albumin binding: taking advantage of modular Nanobody technology

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5662768

Fluorescent analogs of cyclic ADP-ribose: synthesis, spectral characterization, and use

15 August 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-017-14112-6

inferred from DOI database lookup

7 January 2021

based on heuristic

CD38-Targeted Immunochemotherapy in Refractory Multiple Myeloma: A New Horizon

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-017-14112-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Monoclonal Antibodies in Multiple Myeloma Come of Age.

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FS41598-017-14112-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/S41598-017-14112-6

1 reference

9 January 2018

PMC publication ID

5662768

1 reference

9 January 2018

PubMed publication ID

29084989

1 reference

9 January 2018